Neotron is now accredited to perform HMO analysis in infant formula using the official AOAC 2022.07 method, covering seven key HMOs.
Human milk oligosaccharides (HMOs) are naturally occurring carbohydrates found in breast milk and are considered essential contributors to several well‑documented benefits of breastfeeding.
HMOs support the development of healthy gut microbiota, strengthen immune defences, and promote overall infant well‑being.
As selected HMOs are increasingly incorporated into infant formula to help replicate these functional benefits, the need for reliable, accurate, and standardized analytical methods has become more critical than ever.
In this context, Neotron laboratory is now accredited to perform HMO analysis using the official AOAC 2022.07 method, with accreditation covering 7 HMOs in infant formula products.
Contact us for more information!
About Neotron
Neotron is a premier European provider of analytical services, specializing in food, feed, pharmaceuticals, and cosmetics. With a focus on precise testing, sensory analysis, and R&D, Neotron ensures compliance with the highest global standards. As an accredited lab Neotron delivers innovative, tailored solutions to meet the diverse product development and quality control needs of its clients.